Glen Santangelo
Stock Analyst at Jefferies
(2.38)
# 2,288
Out of 4,814 analysts
78
Total ratings
44.9%
Success rate
-1.59%
Average return
Main Sectors:
Stocks Rated by Glen Santangelo
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ANIP ANI Pharmaceuticals | Initiates: Buy | $80 | $69.30 | +15.44% | 1 | Mar 14, 2025 | |
| VTRS Viatris | Maintains: Buy | $15 → $13 | $7.39 | +75.91% | 4 | Mar 7, 2025 | |
| WAY Waystar Holding | Initiates: Buy | $51 | $36.44 | +39.96% | 1 | Feb 11, 2025 | |
| XERS Xeris Biopharma Holdings | Reiterates: Buy | $4 → $6 | $4.13 | +45.28% | 2 | Jan 29, 2025 | |
| NVST Envista Holdings | Maintains: Hold | $20 → $22 | $15.19 | +44.83% | 1 | Jan 23, 2025 | |
| XRAY DENTSPLY SIRONA | Downgrades: Hold | $30 → $20 | $12.84 | +55.76% | 2 | Jan 23, 2025 | |
| PCRX Pacira BioSciences | Maintains: Buy | $15 → $18 | $24.68 | -27.07% | 5 | Sep 24, 2024 | |
| PGNY Progyny | Maintains: Buy | $31 → $24 | $21.44 | +11.94% | 4 | Sep 19, 2024 | |
| TDOC Teladoc Health | Maintains: Hold | $8 → $10 | $6.83 | +46.41% | 6 | Sep 17, 2024 | |
| HIMS Hims & Hers Health | Maintains: Hold | $14 → $23 | $27.22 | -15.50% | 4 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $23 | $13.64 | +68.68% | 4 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $41 → $44 | $26.94 | +63.33% | 3 | Jun 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $17 | $8.44 | +101.42% | 1 | Dec 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $230 | $148.66 | +54.72% | 1 | Dec 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $0.49 | +1,951.28% | 2 | Dec 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $70 | $23.50 | +197.87% | 2 | Jul 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $5.5 | $0.55 | +900.00% | 1 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $4.08 | +292.16% | 1 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $14 | $2.57 | +444.75% | 1 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $75 | $9.17 | +717.88% | 1 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $78 → $46 | $53.20 | -13.53% | 2 | May 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $62 → $80 | $84.52 | -5.35% | 2 | Mar 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $31 → $28 | $3.85 | +627.27% | 2 | Mar 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $70 | $23.94 | +192.40% | 1 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $120 | $6.99 | +1,616.74% | 3 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $2 | $2.67 | -25.09% | 1 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $47 | $4.48 | +950.28% | 1 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $36 | $2.53 | +1,325.74% | 1 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $67.28 | - | 3 | Mar 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $173 → $169 | $697.08 | -75.76% | 5 | May 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $31.33 | - | 2 | Jan 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $134.68 | - | 4 | Dec 16, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $79 → $82 | $64.28 | +27.57% | 2 | Apr 24, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $250 | $171.41 | +45.85% | 1 | Dec 8, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $78 | $10.80 | +622.22% | 1 | Dec 4, 2017 |
ANI Pharmaceuticals
Mar 14, 2025
Initiates: Buy
Price Target: $80
Current: $69.30
Upside: +15.44%
Viatris
Mar 7, 2025
Maintains: Buy
Price Target: $15 → $13
Current: $7.39
Upside: +75.91%
Waystar Holding
Feb 11, 2025
Initiates: Buy
Price Target: $51
Current: $36.44
Upside: +39.96%
Xeris Biopharma Holdings
Jan 29, 2025
Reiterates: Buy
Price Target: $4 → $6
Current: $4.13
Upside: +45.28%
Envista Holdings
Jan 23, 2025
Maintains: Hold
Price Target: $20 → $22
Current: $15.19
Upside: +44.83%
DENTSPLY SIRONA
Jan 23, 2025
Downgrades: Hold
Price Target: $30 → $20
Current: $12.84
Upside: +55.76%
Pacira BioSciences
Sep 24, 2024
Maintains: Buy
Price Target: $15 → $18
Current: $24.68
Upside: -27.07%
Progyny
Sep 19, 2024
Maintains: Buy
Price Target: $31 → $24
Current: $21.44
Upside: +11.94%
Teladoc Health
Sep 17, 2024
Maintains: Hold
Price Target: $8 → $10
Current: $6.83
Upside: +46.41%
Hims & Hers Health
Jun 27, 2024
Maintains: Hold
Price Target: $14 → $23
Current: $27.22
Upside: -15.50%
Jun 27, 2024
Maintains: Buy
Price Target: $19 → $23
Current: $13.64
Upside: +68.68%
Jun 7, 2024
Upgrades: Buy
Price Target: $41 → $44
Current: $26.94
Upside: +63.33%
Dec 19, 2023
Initiates: Buy
Price Target: $17
Current: $8.44
Upside: +101.42%
Dec 19, 2023
Assumes: Buy
Price Target: $230
Current: $148.66
Upside: +54.72%
Dec 15, 2023
Reiterates: Buy
Price Target: $10
Current: $0.49
Upside: +1,951.28%
Jul 25, 2023
Reinstates: Buy
Price Target: $70
Current: $23.50
Upside: +197.87%
Oct 21, 2022
Initiates: Hold
Price Target: $5.5
Current: $0.55
Upside: +900.00%
Oct 21, 2022
Initiates: Buy
Price Target: $16
Current: $4.08
Upside: +292.16%
Oct 21, 2022
Assumes: Buy
Price Target: $14
Current: $2.57
Upside: +444.75%
Oct 21, 2022
Assumes: Buy
Price Target: $75
Current: $9.17
Upside: +717.88%
May 18, 2022
Maintains: Buy
Price Target: $78 → $46
Current: $53.20
Upside: -13.53%
Mar 28, 2022
Maintains: Buy
Price Target: $62 → $80
Current: $84.52
Upside: -5.35%
Mar 17, 2022
Upgrades: Buy
Price Target: $31 → $28
Current: $3.85
Upside: +627.27%
Dec 2, 2021
Initiates: Buy
Price Target: $70
Current: $23.94
Upside: +192.40%
Dec 2, 2021
Initiates: Hold
Price Target: $120
Current: $6.99
Upside: +1,616.74%
Dec 2, 2021
Initiates: Hold
Price Target: $2
Current: $2.67
Upside: -25.09%
Dec 2, 2021
Initiates: Buy
Price Target: $47
Current: $4.48
Upside: +950.28%
Dec 2, 2021
Initiates: Buy
Price Target: $36
Current: $2.53
Upside: +1,325.74%
Mar 17, 2021
Downgrades: Neutral
Price Target: n/a
Current: $67.28
Upside: -
May 21, 2020
Maintains: Hold
Price Target: $173 → $169
Current: $697.08
Upside: -75.76%
Jan 7, 2020
Upgrades: Buy
Price Target: n/a
Current: $31.33
Upside: -
Dec 16, 2019
Downgrades: Neutral
Price Target: n/a
Current: $134.68
Upside: -
Apr 24, 2018
Maintains: Buy
Price Target: $79 → $82
Current: $64.28
Upside: +27.57%
Dec 8, 2017
Initiates: Hold
Price Target: $250
Current: $171.41
Upside: +45.85%
Dec 4, 2017
Initiates: Hold
Price Target: $78
Current: $10.80
Upside: +622.22%